IndraLab

Statements


Dominant-negative TREK-1 mutant inhibits KCNK2. 1 / 1
| 1

reach
"Moreover, the increased cell proliferation rate of PC3 cells and TREK-1 overexpressing CHO cells could be reduced when TREK-1 current was reduced by overexpression of a dominant negative TREK-1 mutant or when cells were exposed to a TREK-1 inhibitor."